An Open-Label Trial of Tocilizumab in Schizophrenia
Phase of Trial: Phase I
Latest Information Update: 10 Oct 2015
At a glance
- Drugs Tocilizumab (Primary)
- Indications Schizophrenia
- Focus Proof of concept; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 06 Oct 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 04 Nov 2014 Planned End Date changed from 1 Sep 2013 to 1 Aug 2015 as reported by ClinicalTrials.gov record.